Organization · Venture Capital
XGEN Venture
XGEN Venture is an Italian alternative investment fund manager specializing in early-stage investments in life sciences companies. Established in 2021, it focuses on translating high-level science into solutions for unmet medical needs.
Overview
What XGEN Venture does
What XGEN Venture is
XGEN Venture is an Italian alternative investment fund manager specializing in early-stage investments in life sciences companies. Established in 2021, it focuses on translating high-level science into solutions for unmet medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find XGEN Venture elsewhere
Open the official website or a supported primary organization account.
Capability profile
XGEN Venture as a funder
Investment thesis
XGEN Venture focuses on early-stage investments in private life sciences companies, translating high-level science into solutions for patients with unmet medical needs.
Focus narrative
XGEN Venture specializes in early-stage investments in private research and development companies within the life sciences sector. The organization targets companies that address high unmet medical needs, focusing on therapeutics, MedTech, diagnostics, and digital health.
Value beyond capital
XGEN Venture provides operational support through a network of venture partners, alongside scientists and entrepreneurs, to create and invest in portfolio companies that address significant medical challenges.
Focus and fit
- Stages
- Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Notable portfolio companies include: Page Therapeutics (breakthrough cancer therapies), Nouscom (cancer immunotherapy), Protembis (improving cardiovascular procedures), TES Pharma (drug discovery for orphan receptors), iOnctura (therapies for hard-to-treat cancers), and an undisclosed gene-therapy startup for rare diseases.
Common questions
What to know about XGEN Venture
Upseed classifies XGEN Venture under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.